CVS Health, Walmart and Walgreens Played Role in Opioid Crisis: Ohio Jury

THURSDAY, Nov. 24, 2021 (HealthDay News) -- CVS Health, Walmart and Walgreens contributed to opioid overdoses and deaths in two Ohio counties, a federal jury in Cleveland found Tuesday.
The first jury verdict in an opioids case came in the closely watched test case and may prove encouraging to plaintiffs in thousands of lawsuits across the United States using the same legal strategy -- that the companies contributed to a "public nuisance," The New York Times reported.
That argument was rejected this month by judges in California and Oklahoma in cases against opioid manufacturers.
The Ohio case is the first time the retail side of the drug industry has been held accountable in the U.S. opioid crisis, the Times reported. CVS Health, Walmart and Walgreens are three of the nation's largest pharmacy chains.
Following the verdict, the trial judge will decide how much each of the pharmacy chains will have to pay Lake and Trumbull counties in northeastern Ohio, the Times reported.
The counties' lawyers said the three companies turned a blind eye to suspicious opioid orders for years. Eventual oversight requirements were "too little, too late," said Mark Lanier, the counties' lead trial lawyer, the Times reported.
Overdose deaths from illegal opioids have reached record levels during the COVID-19 pandemic, new U.S. government data show, the Times reported.
More information
Visit the National Institute of Drug Abuse for more on opioids.
Related Posts
Demasiados carbohidratos ‘malos’ y carne: la dieta fomenta el aumento en la diabetes tipo 2
MARTES, 18 de abril de 2023 (HealthDay News) -- La mayoría de los casos de...
La inflamación cardiaca a largo plazo afecta a 1 de cada 8 pacientes hospitalizados con COVID
MIÉRCOLES, 25 de mayo de 2022 (HealthDay News) -- Un año tras ser hospitalizados...
MS-Specific Internet-Based Therapy Program Can Cut Depressive Symptoms
TUESDAY, Oct. 17, 2023 (HealthDay News) -- A multiple sclerosis (MS)-specific...
New Drug Combo Buys More Time for Advanced Endometrial Cancer Patients
TUESDAY, March 28, 2023 (HealthDay News) -- Researchers have discovered that two...